About Cardiologs Technologies
Cardiologs Technologies is a pioneering AI-powered cardiac diagnostics company that has been integrated into Philips Healthcare. The company develops medical-grade artificial intelligence solutions for electrocardiogram (ECG) analysis, specifically targeting the detection and diagnosis of cardiac arrhythmias. Cardiologs made history as the first AI solution approved by the FDA for ECG analysis in 2017. The company's flagship product, the Cardiologs Holter platform, uses deep neural network (DNN) technology and cloud-based infrastructure to analyze continuous ambulatory ECG recordings. Built upon a foundation of over 200 million ECG recordings, the AI engine analyzes ECG waveforms holistically, mimicking human brain function to handle complex cardiac patterns more effectively than traditional rule-based algorithms. The platform can detect more than 20 types of cardiac events, including atrial fibrillation, ventricular tachycardia, various types of heart blocks, and premature complexes. Cardiologs serves healthcare providers and cardiac diagnostic service organizations globally, with their AI technology used across five continents to diagnose over 2 million patients annually. The company has demonstrated significant clinical impact, including a 42% reduction in Holter analysis time and a 10-fold reduction in atrial fibrillation false positives compared to traditional methods. With over 20 peer-reviewed scientific publications validating their algorithms, Cardiologs continues to advance cardiac care by exploring ECG biomarkers and smartwatch-based cardiac monitoring capabilities.
Clinical Focus
Medical conditions and clinical areas addressed by Cardiologs Technologies.
Who It Serves
Milestones & Awards
Recent Milestones
Integration into Philips Healthcare portfolio. Investigating smartwatch ECG analysis and ECG biomarker capabilities. Over 200M recordings in training database as of October 2023.
Awards & Recognition
First AI solution approved by FDA for ECG analysis (2017)
Key Partnerships
Social & Media
Latest Updates
Press release | June 29, 2026University Health in San Antonio selects Philips enterprise monitoring platform to transform patient monitoring and advance system-wide standardization as patient volume grows
3w ago
Press release | June 09, 2026AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
1mo ago
Media updates: Philips Respironics voluntary June 2021 recall notification
Just launched
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.